Increased plaque structural stress (PSS) is a potential mechanism promoting plaque rupture, with rupture occurring when intraplaque stress exceeds the material strength of the fibrous cap. 4 PSS can be calculated through an engineering technique known as finite element analysis (FEA), which presents a defined solution through synthesis of multiple variables, including plaque geometry, tissue material properties, and hemodynamic forces. FEA constructed on ex vivo data derived from histology demonstrated that ruptured plaques are associated with higher PSS levels. 5 In addition, idealized Background-Atherosclerotic plaques underlying most myocardial infarctions have thin fibrous caps and large necrotic cores; however, these features alone do not reliably identify plaques that rupture. Rupture occurs when plaque structural stress (PSS) exceeds mechanical strength. We examined whether PSS could be calculated in vivo based on virtual histology (VH) intravascular ultrasound and whether PSS varied according to plaque composition, subtype, or clinical presentation. Methods and Results-A total of 4429 VH intravascular ultrasound frames from 53 patients were analyzed, identifying 99 584 individual plaque components. PSS was calculated by finite element analysis in whole vessels, in individual plaques, and in higher-risk regions (plaque burden ≥70%, mean luminal area ≤4 mm 2 , noncalcified VH-defined thin-cap fibroatheroma). Plaque components including total area/arc of calcification (R 2 =0.33; P<0.001 and R 2 =0.28; P<0.001) and necrotic core (R 2 =0.18; P<0.001 and R 2 =0.15; P<0.001) showed complex, nonlinear relationships with PSS. PSS was higher in noncalcified VH-defined thin-cap fibroatheroma compared with thick-cap fibroatheromas (median [Q1-Q3], 8.44 [6.97-10.64] versus 7.63 [6.37-9.68]; P=0.002). PSS was also higher in patients with an acute coronary syndrome, where mean luminal area ≤4 mm 2 (8.24 [7.06-9.93] versus 7.72 [6.33-9.34]; P=0.03), plaque burden ≥70% (9.18 [7.44-10.88] versus 7.93 [6.16-9.46]; P=0.02), and in noncalcified VH-defined thin-cap fibroatheroma (9.23 [7.33-11.44] versus 7.65 [6.45-8.62]; P=0.02).
C oronary plaque rupture is the precipitating event in two thirds of myocardial infarctions, 1 with ruptured plaques exhibiting a large, necrotic, lipid core and superimposed thrombus. 2 The proposed precursor lesion has a thin overlying fibrous cap separating the core from the lumen and is termed a thin-cap fibroatheroma (TCFA). 3 Currently, there is a major emphasis on diagnostic modalities that can identify and stratify plaques before rupture.
Clinical Perspective on p 470
FEA models have shown that altering plaque composition, including increasing necrotic core size, decreasing fibrous cap thickness, and microcalcification, can significantly elevate PSS. [6] [7] [8] However, until recently, in vivo imaging modalities for coronary atherosclerosis have lacked sufficient resolution for accurate and reproducible identification of both plaque composition and architecture. Thus, limited data exist on PSS distribution in coronary atherosclerosis in vivo, and whether in vivo PSS values are affected by plaque composition, subtype, or clinical presentation is unknown.
Virtual histology intravascular ultrasound (VH-IVUS) is an invasive, ultrasound-based modality that uses backscatter to identify plaque composition. 9 VH-IVUS reliably identifies plaque components including dense calcium, fibrofatty, fibrous tissue and necrotic core, providing a VH corollary of histological definitions. 10 Prospective studies using VH-defined plaque classification algorithms have shown an association between VH-defined TCFA (VHTCFA) and subsequent major adverse cardiovascular events 11, 12 ; however, the absolute event rate per individual higher-risk lesion was low (<10% at 3 years). Thus, additional methods for assessment of plaque vulnerability are required to improve our ability to predict plaque rupture.
We present a methodology using FEA to calculate PSS based on in vivo VH-IVUS data. We examined PSS variability and distribution throughout whole vessels, whole plaques, and in specific higher-risk plaque regions. We assessed the relationship between PSS and plaque composition and subtype and whether PSS calculation provides incremental information beyond VH-IVUS imaging to identify clinical presentation. We find that PSS is highly heterogeneous and that plaque composition, subtype, and clinical presentation significantly affect PSS. The positive predictive power of VH-IVUS to identify clinical presentation was improved through addition of PSS. If validated prospectively, FEA-VH-IVUS may improve stratification of higher-risk coronary plaques.
Methods

Procedural Details
The VH-IVUS in Vulnerable Atherosclerosis (VIVA) study protocols were approved by the Cambridge Research Ethics Committee as published previously. 11 Briefly, following informed consent, 170 patients undergoing percutaneous coronary intervention underwent 3-vessel VH-IVUS (100 stable angina pectoris [SAP] and 70 troponin-positive acute coronary syndrome [ACS]). Demographic data were obtained at recruitment and hemodynamic data from the guiding catheter at the time of VH-IVUS imaging. VH-IVUS data were acquired before stenting with 20 MHz Eagle-Eye Gold catheters (Volcano Corporation, Rancho Cordova) using motorized pullback at 0.5 mm/s after administration of intracoronary glycerin trinitrate. Image analysis was performed offline on S5 consul software version 3.1 (Volcano Corporation) and verified by Krakow Cardiovascular Research Institute core laboratory using Volcano Image Analysis Software version 3.0.394. A plaque was defined when plaque burden (PB) was >40% of vessel cross-sectional area for 3 consecutive frames. Both gray-scale (GS) and VH-defined IVUS parameters were calculated along each artery, including PB, minimal luminal area (MLA), and VH-defined plaque composition. Noncalcified VHTCFAs (ncVHTC-FAs) were defined as plaques with confluent necrotic core (>10% of plaque cross-sectional area) in contact with the lumen, with minimal dense calcium (≤10% plaque cross-sectional area). Full details of plaque classification are shown in Table I in the Data Supplement. To minimize interarterial mechanical forces in the analysis, only culprit left anterior descending arteries were studied. Culprit arteries were defined by dynamic electrocardiographic criteria (ST-segment shift or T-wave inversion) combined with angiographic appearance at percutaneous coronary intervention.
FEA Modeling
Vessel geometry and plaque architecture were reconstructed from in vivo radiofrequency data acquired at each R-wave peak ( Figure 1A ). Plaques were considered suitable for modeling where PB ≥40%. Imaging data were imported into analysis software (proprietary A, Virtual histology intravascular ultrasound image showing dense calcification (white), necrotic core (red), fibrous (green), and fibrofatty tissue (light green). B, Reconstructed geometry and segmented plaque components used for FEA. C, Nine-node quadrilateral mesh with ≈10 000 elements constructed. D, Band plot of PSS identifying regions with high stress concentration (arrows). E, Band plot of variation of PSS during 1 cardiac cycle, illustrating regions with high stress variation (arrows).
code, MATLAB R2011b, The MathWorks Inc), allowing construction of 2-dimensional (2D) vessel cross-sections for FEA modeling ( Figure 1B ). Because data were obtained during diastole, circumferential vessel shrinkage was applied, permitting generation of a zero-pressure condition as a basis for computational simulation. 13 Investigators (Z.T., A.J.B.) were blinded to both plaque classification and clinical presentation for all FEA modeling. Individual VH-defined plaque components were segmented and assumed to be incompressible, piecewise homogenous, nonlinear isotropic, and hyperelastic as described by the modified Mooney-Rivlin strain energy density function:
where I 1 is the first invariant of deformation tensor and c 1 , D 1 , and D 2 are material parameters derived from previous experimental work 14 and include the following: arterial vessel wall, c 1 =36.8 kPa, D 1 =14.4 kPa, D 2 =2; fibrous tissue, c 1 =73.6 kPa, D 1 =28.8 kPa, D 2 =2.5; necrotic lipid core, c 1 =2 kPa, D 1 =2 kPa, D 2 =1.5; and calcification, c 1 =368 kPa, where υ 1 [ ] and σ ij     are the displacement vector and stress tensor, respectively, ρ=density of each component, and t=time. The entire plaque model was then meshed using 9-node quadrilaterals, generating ≈10 000 elements and 40 000 nodes per model ( Figure 1C ). Both displacement and strain were assumed to be large. There was no relative movement at the interface of atherosclerotic components and relative energy tolerance was set to 0.005. Two adjacent points were fixed to prevent rigid body displacement. Dynamic loading conditions were generated from simultaneous coronary pressure recordings taken during VH-IVUS acquisition, with pressure at the outer boundary set to zero.
Throughout the analysis, vessel wall PSS is described using maximum principal stress. Variation in PSS during 1 cardiac cycle was defined as:
in which the subscript i=ith integration node and the superscript t=time were computed. PSS was subsequently normalized by coronary pressure, creating a ratio for comparison between patients. Normalized PSS ( Figure 1D ) and its variation (change in normalized PSS during a cardiac cycle; Figure 1E ) were used for all statistical analysis. All FEA simulations were performed using ADINA 8.6.1 (ADINA R&D, Inc.).
Statistical Analysis
Data were assessed for normality using the Shapiro-Wilk test. Normally distributed continuous outcomes are presented as mean (SD) and were compared using unpaired t test, with non-normal outcomes presented as median (Q1-Q3) and compared using 
Results
Baseline Patient and VH-IVUS Demographics
Fifty-three patients with left anterior descending artery culprit lesions were included in this analysis, 23 presenting with an ACS and 30 with SAP. Patient demographics were similar between groups ( 
Calculation and Reproducibility of PSS
Plaque and vessel geometry was constructed from 4429 in vivo VH-IVUS frames comprising 99 584 individual plaque components. The FEA modeling comprised 4 individual steps: first, VH-IVUS plaque geometry and that of individual plaque components were imported as 2D cross-sectional images and segmented manually; second, a zero-pressure condition was created as a basis for the computational simulation; third, a 9-node quadrilateral mesh with ≈10 000 elements was constructed for the whole cross-section; fourth, dynamic simulations were performed using each patient's coronary arterial pressure as loading conditions for simulations ( Figure 1 ). The methodology used allowed us to generate longitudinal reconstructions of both PSS and variation in PSS during 1 cardiac cycle in the whole artery, in individual plaques, and in single VH-IVUS frames ( Figure 2 ). FEA is semiautomated but involves manual correction to determine plaque component boundaries; we therefore assessed both the intra-and interobserver variability of PSS calculations in 5% of frames analyzed. The intraclass correlation coefficient for intraobserver variability, representing absolute agreement between PSS values within models, was excellent at 0.99 (95% confidence interval [CI], 0.97-0.99; P<0.001). Reproducibility was also excellent with an interobserver variability of 0.98 (95% CI, 0.97-0.99; P<0.001).
Representative PSS values from 2 observers within a coronary plaque are shown in Figure I in the Data Supplement.
Distribution of PSS
PSS values calculated for each VH frame showed a wide distribution, ranging from 2.81 to 29.03 (median, 9.04; Q1-Q3, 7.28-11.40). 99.2% of PSS values were located in the plaque, with 0.8% located in the disease-free contralateral vessel wall. Importantly, there were marked differences in PSS within individual VH frames, with values of <15% of peak PSS within 100 to 200 μm of maximal PSS points ( Figure II in the Data Supplement). Indeed, marked differences between PSS values were found in frames in which plaque classification was identical ( Figure 3 ). Whole plaques also showed marked variation in PSS over short lengths of VH-IVUS pullback with a large range from 5.33 to 14.02. For example, PSS varied from 9.15 to 21.45 for 3 VH frames, equating to ≈1.5 mm of coronary plaque at a heart rate of 60 bpm. This led to a wide variability of both median and interquartile range for individual plaques ( Figure III in the Data Supplement).
Plaque Composition and PSS
The marked variation of PSS within a single frame or plaque and between plaques with the same subtype highlight the heterogeneity of materials that comprise the plaque. Several plaque features have been linked to subsequent rupture in prospective studies, namely, spotty calcification, large necrotic core, thin fibrous cap, PB ≥70%, and MLA ≤4 mm 2 . Although idealized and ex vivo FEA simulations have suggested that these features may affect PSS, their effect on PSS measured in vivo is unknown. We therefore studied the effect of total calcified and necrotic core component area, arc, and circumference on PSS. There were nonlinear relationships between PSS and area (R 2 =0.33; P<0.001), arc (R 2 =0.28; P<0.001), and total circumferential component length (R 2 =0.32; P<0.001) of calcification within a plaque ( Figure 4A-4C ). PSS increased with increasing calcification but then seemed to plateau or even reduce when calcification became more extensive. There were similar, albeit weaker, nonlinear relationships between PSS and necrotic core area (R 2 =0.18; P<0.001), arc (R 2 =0.15; P<0.001), and total circumferential component length (R 2 =0.19; P<0.001; Figure 4D -4F). Again, there was an increase in PSS with larger area/arc of necrotic core, although a plateau was observed for total circumferential component length, implying that unlike calcification, multiple lipid pools may not amplify PSS. In addition, there was a positive correlation between increasing luminal area and PSS (r S =0.39; P<0.0001) but no correlation with PB (r S =−0.03; P=0.11; Figure 5 ). Although measurement of fibrous cap thickness is beyond the spatial resolution of VH-IVUS, PSS was significantly higher in VH-IVUS-defined TCFAs (9.19 [7.45-11 .62]) compared with lower-risk plaques, including both thick-cap fibroatheromas (7.63 [6.40-9.66]; P=0.01) and pathological intimal thickening (6.47 [5.98-7 .73]; P<0.001).
Clinical Presentation and PSS
The ability of VH-IVUS to identify plaques underlying different clinical presentation is controversial. We therefore examined whether PSS values were different in patients presenting with ACS versus SAP and whether combining PSS with VH-IVUS improved accuracy for ACS presentation. PSS and variation in PSS were similar between patients with SAP and ACS on both whole culprit vessel and whole culprit plaque analyses (Table 3) . However, because plaque rupture is likely to be focal, and PSS varies markedly within a plaque (Figures 2 and 3 , Figure III in the Data Supplement), higher-risk plaque features may be more important than either whole vessel or whole plaque parameters. We analyzed frames having PB ≥70%, MLA ≤4 mm 2 , and ncVHTCFA because these features confer higher risk in prospective VH-IVUS studies. In frames in which the MLA was ≤4 mm 2 , PSS levels were significantly greater in patients with ACS versus SAP (8.24 [7.06-9.93] versus 7.72 [6.33-9.34]; P=0.03). Both PSS and PSS variation were also greater in patients with ACS in frames with PB ≥70% and ncVHTCFA (Table 3) . When these features were combined in prospective studies, the hazard ratio for major adverse cardiovascular events was significantly increased. 11, 12 Consistent with this, PSS was amplified markedly in patients with ACS versus SAP when both MLA ≤4 mm 2 Although MLA ≤4 mm 2 , PB ≥70%, and ncVHTCFA are associated with increased major adverse cardiovascular events in prospective studies, lesions with these features have a low absolute event rate. We therefore examined whether combining PSS with VH-IVUS provides incremental information to identify clinical presentation. Increasing quartiles of PSS resulted in increasing positive predictive values in all higher-risk areas; however, this effect was most prominent in ncVHTCFA, where PSS ≥10.22 resulted in a positive predictive value of 91.4% Figure 4 . Relationship between plaque structural stress (PSS) and plaque components. Nonlinear regression curves (blue dotted line) with 95% confidence intervals (black lines) illustrating best-fit relationships between PSS and (A) total area of dense calcium (mm 2 ), (B) maximal arc of dense calcium (°), (C) total circumferential length of dense calcium components (mm), (D) total area of necrotic core (mm 2 ), (E) maximal arc of necrotic core (°), and (F) total circumferential length of necrotic core components (mm). ( Table 4) , albeit with a low negative predictive value. To assess the ability of PSS alone and in combination to identify clinical presentation, receiver operating characteristic curve analysis was performed without refinement and then combined with 3 higher-risk VH-IVUS parameters (ncVHTCFA, PB ≥70%, and MLA ≤4 mm 2 ). PSS alone had poor discriminatory power to predict ACS presentation (AUC, 0.48; 95% CI, 0.46-0.50; P=0.44). However, power increased when PSS was combined with ncVHTCFA (AUC, 0.72 versus 0.56; P<0.0001) or with PB ≥70% (AUC, 0.62 versus 0.51; P<0.0001), but not with MLA ≤4 mm 2 (AUC, 0.59 versus 0.58; P=0.73). Combining ncVHTCFA with PB ≥70% resulted in an AUC of 0.82 (95% CI, 0.69-0.95; P=0.006), and combining ncVHTCFA with MLA ≤4 mm 2 gave an AUC of 0.83 (95% CI, 0.77-0.90; P<0.0001; Figure 6 ).
Discussion
Observational studies have confirmed that TCFAs represent the major plaque substrate for rupture. 2 Nevertheless, prospective studies using VH-IVUS found that overall event rates at 3 years attributable to TCFAs were low, 11, 12 indicating that additional plaque markers are required to predict rupture and improve patient risk stratification. Plaque rupture is a dynamic process, determined by multiple factors including plaque composition, plaque architecture, and hemodynamic forces. Because FEA calculation of PSS integrates and synthesizes these coexisting variables, FEA may represent a powerful tool to determine the features of coronary plaques that promote rupture.
There are several novel and important aspects to our findings. We present a robust and reproducible FEA methodology to calculate PSS and demonstrate that PSS varies markedly over the length of a coronary plaque and within a single 2D section. We find complex nonlinear relationships between plaque composition and PSS but with larger PSS values observed in higher-risk plaques. In addition, PSS was elevated in regions that confer prospective risk in patients presenting with an ACS. Finally, combining PSS with VH-IVUS provides incremental information to identify clinical presentation. If validated prospectively, our work moves coronary FEA from a research tool to a potentially useful clinical modality to risk stratify both patients and their plaques.
FEA biomechanical analysis has been used previously in human coronary atherosclerosis, but studies either used idealized modeling or were ex vivo. For example, eccentric lipid pools were shown to concentrate PSS toward the plaque cap, and regions of high stress correlated with intimal tear sites at autopsy. 4 PSS was elevated by decreasing fibrous cap thickness and reduced by increasing lesion stenosis severity. 6 Histological examination demonstrated that ruptured plaques have a significantly higher PSS than stable plaques, suggesting that regions of high stress may promote plaque rupture. 5 Furthermore, 82% of plaque fractures occurred at regions of high stress in an ex vivo model of plaque rupture induced by balloon angioplasty. 15 Despite these ex vivo studies, there are few published in vivo studies of PSS. One study using GS-IVUS assessed the longitudinal variation in PSS along 15 coronary plaques. 16 Consistent with ex vivo modeling, PSS increased as fibrous cap thickness decreased and was amplified by superficial calcification. However, because GS-IVUS was used, the effect of plaque composition or classification on PSS could not be accurately assessed. Furthermore, no data exist on the relationship between clinical events and PSS, whereas previous studies have typically used basic modeling techniques, assuming linear properties for biological tissues and failing to incorporate the dynamic loading of arterial pressure.
We show that FEA based on VH-IVUS is a reproducible quantitative technique to calculate PSS, which may have the ability to determine the rupture potential of a coronary plaque. PSS is associated with specific plaque features that can be identified in vivo by VH-IVUS, including calcification, necrotic core, and plaque subtype. PSS increases initially with early plaque calcification but then plateaus when calcification becomes extensive. This finding corresponds with studies showing that small areas of spotty calcification on both IVUS 17 and computerized tomography 18 are associated with higher-risk plaques and ex vivo modeling, showing that calcification can amplify PSS. 7 PSS also increases as necrotic core size or arc expands, again consistent with ex vivo work, 8 and that a large necrotic core is associated with ruptured plaques. 2 Although plaque fibrous cap thickness could not be measured directly, VH-defined thick cap fibroatheromas had lower PSS than VHTCFAs, suggesting that fibrous cap thickness is an important determinant of PSS. 6 In contrast, markers of plaque size such as MLA and PB were either inversely (MLA) or did not (PB) correlate with PSS. This is consistent with previous studies showing a negative association between peak stress and stenosis severity on idealized coronary artery cross-sections 6 and no association between mechanical stress and PB in carotid plaques. 19 Importantly, these findings suggest that PSS may indicate the propensity for plaque rupture independent of other VH-IVUS higher-risk features. We find that FEA also provides important insights into the biology of coronary plaques. There were wide variations of PSS within both individual VH-IVUS frames and longitudinally over short segments of the same plaque; variations in PSS related to different plaque components, their size, and orientation within lesions. Although atherosclerosis is a diffuse disease, plaque rupture is likely a focal event, occurring in specific areas of plaque weakness. 20 PSS was unequally distributed across vessels and plaques, indicating that regions of plaque vulnerability may exist over an exceptionally short distance. Current coronary imaging studies frequently use hierarchical plaque classification algorithms, requiring the presence of specific plaque compositional features over a series of frames for categorization. 11, 12 Our data suggest that summarized or averaged variables over multiple frames that attempt to describe plaques may dilute their true overall risk of rupture. FEA VH-IVUS may therefore represent a unique, refined, and targeted approach for describing the heterogeneity within individual lesions and ultimately for estimating risk of plaque rupture.
In addition, we observed that areas of high PSS were frequently seen deep within the plaque structure and not always located around the shoulder or luminal border. Although the significance of this finding is unclear, these deeper sites of high stress may act as foci for intraplaque rupture and hemorrhage. Indeed, ex vivo biomechanical studies in carotid plaques have previously found high stress concentrations located around areas of neovascularization, 21 which might result in subsequent intraplaque hemorrhage. 22 This dynamic and often subclinical process may promote plaque growth, increasing PB and reducing vessel luminal area. Indeed, measures of increasing burden and reduced lumen assessed as PB ≥70% and MLA ≤4 mm 2 , respectively, are associated with future cardiovascular events. However, it should be noted that an association between events and PB ≥70% or MLA ≤4 mm 2 might reflect whether a clot of any given size will occlude flow, leading to ACS.
The ability of VH-IVUS alone to identify presentation with ACS is controversial, with studies reporting conflicting data on whether VH-derived plaque composition differs between patient groups. 22, 23 We find that PSS and variation in PSS were higher in patients with ACS but only at VH-IVUS-determined higher-risk sites (MLA ≤4 mm 2 , PB ≥70%, and ncVHTCFA) and not in whole vessels or whole culprit plaques; combinations of these higher-risk features amplified PSS further. The incremental information gained by FEA VH-IVUS to identify clinical presentation is demonstrated in 2 ways. First, increasing quartiles of PSS in higher-risk regions significantly increased the positive predictive ability of VH-IVUS to identify patients presenting with ACS (from 65.2% up to 91.4% in ncVHTCFA). Second, receiver operating characteristic curves highlight that PSS combined with prospective higher-risk VH markers of vulnerability can be used effectively to identify clinical presentation. Although our data do not yet demonstrate clinical usefulness, FEA VH-IVUS seems to offer additional information over anatomic imaging alone.
There are some limitations to our study. For example, although VH-IVUS was acquired before stenting, the effects of plaque rupture and subsequent thrombosis and healing before imaging on PSS are unknown, and a prospective validation of PSS combined with other higher-risk features to predict major adverse cardiovascular events in a larger patient cohort is required. All FEA simulations were 2D, and the effect of blood flow was not modeled; however, because PSS within plaques is 10 3 to 10 5 times greater than wall shear stress because of blood flow, it is reasonable to assume that shear plays a limited role in overall plaque stress. 24 The ability of FEA VH-IVUS to estimate plaque stress depends in part on the resolution of VH-IVUS and any inherent limitations in classifying plaques and identifying plaque components. However, to date, VH-IVUS is the only imaging modality that can accurately identify both plaque size and composition in sufficient resolution for FEA modeling and has prospective data that correlate VH-defined plaque features to clinical events. Finally, there are other pathological mechanisms that may give rise to ACS including plaque erosions and calcific nodules; the role of PSS in these processes is yet to be determined.
In summary, we present a novel technique to calculate PSS in coronary plaques based on VH-IVUS imaging. Biomechanical modeling with FEA VH-IVUS is a reproducible method of assimilating in vivo plaque composition, architectural, and hemodynamic data and holds promise for increasing the ability of VH-IVUS to predict plaque rupture.
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